T
Temsunaro Rongsen Chandola
Researcher at Translational Health Science and Technology Institute
Publications - 9
Citations - 116
Temsunaro Rongsen Chandola is an academic researcher from Translational Health Science and Technology Institute. The author has contributed to research in topics: Medicine & Genome. The author has an hindex of 2, co-authored 2 publications receiving 88 citations.
Papers
More filters
Journal ArticleDOI
A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants
Prasad S. Kulkarni,Sajjad Desai,Tushar Tewari,Anand Kawade,Nidhi Goyal,Bishan S Garg,Dinesh Kumar,Suman Kanungo,Veena Kamat,Gagandeep Kang,Ashish Bavdekar,Sudhir Babji,Sanjay Juvekar,Byomkesh Manna,Shanta Dutta,Rama Angurana,Deepika Dewan,Abhijeet Dharmadhikari,Jagdish Kamalaji Zade,Rajeev M. Dhere,Alan Fix,Maureen Power,Vidyasagar Uprety,Varsha Parulekar,Iksung Cho,Temsunaro Rongsen Chandola,Vikash K. Kedia,Abhishek V Raut,Jorge Flores,Hanif Shaikh,Lalit Gupta,Rakesh Patil,Mohd. Aslam,Alok Arya,Farhana Afzal Rafiqi,Subodh S Gupta,Chetna Maliye,P. V. Bahulekar,Kiran Bala,Tajali Nazir Shora,Shahid Hussain,Mihir K. Bhattacharya,Ashis K. Mukhopadhyay,Dilipkumar Pal,Jayanta K. Saha,Ranjitha S Shetty,Muralidhar M Kulkarni,Chythra V. Raj +47 more
TL;DR: The Pentavalent reassortant rotavirus vaccine showed excellent tolerability and a good safety profile when tested for efficacy in infants and the intent to treat analyses confirmed all the per protocol analyses.
Journal ArticleDOI
ROTAVAC® does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial.
Temsunaro Rongsen Chandola,Sunita Taneja,Nidhi Goyal,Kalpana Antony,Kiran Bhatia,Deepak More,Nita Bhandari,Iksung Cho,Krishna Mohan,Sai Prasad,Gvja Harshavardhan,Tataji Surender Rao,Tataji Surender Rao,Sudhanshu Vrati,Maharaj K. Bhan +14 more
TL;DR: It is demonstrated that ROTAVAC® can be safely administered with childhood vaccines without interfering with the immune response to the antigens contained in these vaccines.
Journal ArticleDOI
A multi-country implementation research initiative to jump-start scale-up of outpatient management of possible serious bacterial infections (PSBI) when a referral is not feasible: Summary findings and implications for programs
Yasir Bin Nisar,Samira Aboubaker,Shams El Arifeen,Shabina Ariff,Narendra K. Arora,Shally Awasthi,Adejumoke I. Ayede,Abdullah H Baqui,Ashish Bavdekar,Melkamu Berhane,Temsunaro Rongsen Chandola,Abadi Leul,Salim Sadruddin,Antoinette Tshefu,Robinson D. Wammanda,Assaye K Nigussie,Lee Pyne-Mercier,Luwei Pearson,Neal Brandes,Stephen Wall,Shamim Qazi,Rajiv Bahl +21 more
TL;DR: This multi-country implementation research initiative aimed to learn how to implement the World Health Organization (WHO) PSBI management guideline in diverse contexts, and important lessons will be used to introduce and scale-up implementation in relevant Low- and middle-income countries.
Posted ContentDOI
Genomic analysis unveils the role of genome degradation events and gene flux in the emergence and persistence of S. Paratyphi A lineages
Jobin John Jacob,Agila Kumari Pragasam,Karthick Vasudevan,A. V.,Monisha Priya T,T. T,Pallab Ray,Madhu Gupta,Arti Kapil,Su Bai,Savitha Nagaraj,Karnika Saigal,Temsunaro Rongsen Chandola,Mari Thomas,Ashish Bavdekar,Sheena Evelyn Ebenezer,Jayanthi Shastri,Anuradha De,Shantha Dutta,Anna Perry Alexander,Roshine Mary Koshy,Dasaratha Ramaiah Jinka,Ashita Singh,Sunil Kumar Srivastava,Shalini Anandan,Gordon Dougan,Jacob John,Gagandeep Kang,Balaji Veeraraghavan,Ankur Mutreja +29 more
TL;DR: It is documented that the genome degradation events and gene acquisitions or losses play a major role in the evolution of new S. Paratyphi A lineages/sub-lineages and that the six characteristic missense mutations associated with the lipopolysaccharide biosynthesis genes of S.Paratyphoid fever confer only a low structural impact and would therefore have minimal impact on vaccine effectiveness.
Journal ArticleDOI
Enteral Calcium or Phosphorus Supplementation in Preterm or Low Birth Weight Infants: a Systematic Review and Meta-analysis.
Mohan Kumar,Ranadip Chowdhury,Bireshwar Sinha,Ravi Prakash Upadhyay,Temsunaro Rongsen Chandola,Sarmila Mazumder,Sunita Taneja,Nita Bhandari,Tarun Shankar Choudhary +8 more
TL;DR: The evidence is insufficient to determine whether enteral supplementation with calcium or phosphorus for preterm or low birth weight infants who are fed mother's own milk or donor human milk is associated with benefit or harm.